INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 57 filers reported holding INSTIL BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -99.8% | 57 | -99.7% | 0.00% | – |
| Q2 2023 | $9,633 | -83.8% | 17,483 | -80.6% | 0.00% | – |
| Q1 2023 | $59,434 | -99.2% | 89,942 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $7,752,537 | -91.8% | 12,305,616 | -36.7% | 0.00% | -90.0% |
| Q3 2022 | $94,157,000 | +5.1% | 19,454,035 | +0.3% | 0.01% | +11.1% |
| Q2 2022 | $89,581,000 | -54.1% | 19,389,766 | +6.9% | 0.01% | -43.8% |
| Q1 2022 | $194,981,000 | -23.5% | 18,137,713 | +21.8% | 0.02% | -15.8% |
| Q4 2021 | $254,857,000 | +14.5% | 14,895,240 | +19.6% | 0.02% | +5.6% |
| Q3 2021 | $222,668,000 | +9.1% | 12,456,936 | +15.8% | 0.02% | +12.5% |
| Q2 2021 | $204,165,000 | +20.4% | 10,758,361 | +50.6% | 0.02% | +14.3% |
| Q1 2021 | $169,609,000 | – | 7,144,389 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |